Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Vascular Malformations

• Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
• A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
• Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
• Efficacy and Safety of Rapamycin to Complex Vascular Anomalies in Pediatric Patients
• Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions
• Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
• Topical Sirolimus in Cutaneous Lymphatic Malformations
• Efficacy and Safety of Sirolimus to Vascular Anomalies
• Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain
• A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain
• Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)
• Electrosclerotherapy for Capillary Malformations
• Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations
• Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
• the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
• Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
• suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
• Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
• Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias
• Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study
• Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
• Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus
• Novel Treatment for Port Wine Stain Birthmarks
• Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
• The Effects of Aldara as an Adjunct to Laser Treatment
• Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
• Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks
• Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
• Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
• Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
• A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
• A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
• Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks
• Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
• Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
• Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.